NCT00597233View on ClinicalTrials.gov

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

91

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin aspart

DRUG

soluble human insulin

DRUG

insulin NPH

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Junín

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY